Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma

NCT00090038 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
168
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biogen